Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance

Eli Lilly and Company (NYSE:LLY) is one of the 7 Best Compounder Stocks to Buy Now.

Eli Lilly and Company (NYSE:LLY) plans to stop providing 340B discounted drug pricing to certain hospitals that have not complied with claims data reporting requirements introduced on February 1, Fierce Healthcare’s Dave Muoio reported. The move has drawn opposition from hospital groups and calls for federal regulators to intervene. In a June 1 letter to Thomas Engels, administrator of the Health Resources and Services Administration, Lilly said about 70%, or 2,350 distinct entities, have complied with the policy, and that it has sent two rounds of follow-up reminder letters to those that have not.

Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance

On June 2, 2026, Eli Lilly and Company (NYSE:LLY) announced presentation details for the European Hematology Association Annual Meeting, taking place June 11-14 in Stockholm, Sweden. Lilly will present results from the Phase 3 BRUIN CLL-322 study of Jaypirca, a non-covalent Bruton tyrosine kinase inhibitor, as part of a time-limited regimen for patients with previously treated chronic lymphocytic leukemia. Lilly also said Ajax Therapeutics and Kelonia Therapeutics, both pending proposed acquisitions, will present data at the meeting. Ajax will share first clinical results from the Phase 1 AJX-101 study of AJ1-11095 in myelofibrosis, while Kelonia will present additional correlative data from the Phase 1 inMMyCAR study of KLN-1010 in relapsed or refractory multiple myeloma.

Eli Lilly and Company (NYSE:LLY) discovers, develops, manufactures, and markets human pharmaceutical products internationally.

While we acknowledge the risk and potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LLY and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1